For R&D use only.

Canagliflozin

  • Catalog NO.:A25050
  • CAS No. : 842133-18-0
  • Molecular Formula:C24H25FO5S
  • Molecular Weight: 444.52
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS

Product Details

CAS Number 842133-18-0 Appearance
Catalog Number A25050 MDL Number MFCD18251436
Molecular Formula C24H25FO5S Molecular Weight 444.52
Boiling Point Melting Point
Flash Point Density
Synonyms JNJ24831754ZAE; TA 7284;(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements Class
Precautionary Statements Packing Group

Description

Canagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, canagliflozin became the first SGLT2 inhibitor to be approved in the United States.

928672-86-0 (hemihydrate)

842133-18-0 (free)

Related Products

My Tracks: Canagliflozin
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Canagliflozin
JNJ24831754ZAE; TA 7284;(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol